Active	Status	Sponsor type	Region	Phase	Filter
3 Active 3 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Nadolski, Gregory
Trinav, NCT06204159: Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery	Recruiting	N/A	12	US	TACE Catheters	Abramson Cancer Center at Penn Medicine, TriSalus Life Sciences	Hepatocellular Carcinoma, Neuroendocrine Tumors	01/26	06/26
DOORwaY90, NCT04736121: Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients	Active, not recruiting	N/A	100	US	Resin microspheres containing yttrium-90 (Y-90)	Sirtex Medical, Bright Research Partners	Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma	10/25	12/26
NCT05953337: Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)	Recruiting	N/A	120	US	EYE90 Microspheres Treatment	ABK Biomedical	Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer	10/25	10/25